| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022310 |
| Receipt No. | R000025704 |
| Official scientific title of the study | A randomized parallel-group trial for influence of upper and temporal transconjunctival sclerocorneal incision on marginal reflex distance after cataract surgery |
| Date of disclosure of the study information | 2016/06/09 |
| Last modified on | 2016/06/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A randomized parallel-group trial for influence of upper and temporal transconjunctival sclerocorneal incision on marginal reflex distance after cataract surgery | |
| Title of the study (Brief title) | Influence of position of transconjunctival sclerocorneal incision in marginal reflex distance after cataract surgery | |
| Region |
|
|
| Condition | ||
| Condition | cataract | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the marginal reflex distance 1 (MRD1) preoperatively and postoperatively between the two different incision types during cataract srugery |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Marginal reflex distance 1 (MRD1) preoperatively and at three months postoperatively |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Group for an upper 2.4-mm transconjunctival sclerocorneal incision during cataract operation | |
| Interventions/Control_2 | Group for a temporal 2.4-mm transconjunctival sclerocorneal incision during cataract operation | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with cataract | |||
| Key exclusion criteria | Patients with a history of thyroid eye disease, proptosis, enophthalmos, or previous lid or ocular surgery | |||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiro Zako |
| Organization | Aichi Medical University |
| Division name | Department of Ophthalmology |
| Address | 1-1 Karimata, Yazako, Nagakute, Aichi |
| TEL | 0561623311 |
| Mzako@aol.com | |
| Public contact | |
| Name of contact person | Masahiro Zako |
| Organization | Aichi Medical University |
| Division name | Department of Ophthalmology |
| Address | 1-1 Karimata, Yazako, Nagakute, Aichi |
| TEL | 0561623311 |
| Homepage URL | http://www.aichi-med-u.ac.jp/su06/su0611/su061100/__icsFiles/afieldfile/2013/11/01/rin_H25-06.pdf |
| Mzako@aol.com | |
| Sponsor | |
| Institute | Aichi Medical University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 愛知医科大学病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025704 |